What are you looking for?

Bart Swinkels

Dutch and European patent attorney & Of Counsel

As a Dutch and European patent attorney and former partner at NLO I bring more than 30 years of experience in patenting in the life sciences area to the table. And after all that time I am still passionate about finding creative solutions in complex IP situations to help my clients to bring their innovative products to market, with robust protection and free of competitor patents. My areas of expertise include genomics, genome editing, gene therapy, (onco)immunology (engagers, antibodies and vaccines), metabolic engineering, microbiology and breeding of plants or animals. Over the years I have gained extensive experience in handling adversarial proceedings, both before the national courts, as well as in European opposition proceedings up to the Boards of Appeal.

+31621105113

swinkels@nlo.eu

visit my profile

Prior to joining NLO I headed the IP department of Pharming N.V. and I was a patent attorney at DSM. Before entering the world of IP, I did molecular biological research in both academic and industrial settings at DSM, UC San Diego and the Netherlands Cancer Institute. In addition, I represented the Netherlands in the Biotech Committee of the Institute of Professional Representatives before the EPO (EPI).

Bart is among the “IAM Patent 1000 –World's Leading Patent Practitioners” every year since 2012 and among the MIP “IP Stars” every years since 2014.

Education

MSc in Chemistry (cum laude), University of Amsterdam
PhD in Molecular Biology, under Prof. Piet Borst, University of Amsterdam

Publications

Pallard, C. and Swinkels, B. "The role of the function of DNA sequences before and after grant". Life Sciences Intellectual Property Review 2011, p56 - 59.
van Heuvel, M. and Swinkels, B. "Salad days: Tomatoes, broccoli and radish patents" Life Sciences Intellectual Property Review, October 2013.
Swinkels, B. and van Dongen, S. “Can a plant rule supplant a plant decision” Intellectual Assets Management, International Reports, July 2017.